Showing results (2151-2160 of 3,921) with videos related to
Sort By:
Pageof 393
European Journal of Gynaecological Oncology|March 5, 2002
A ten-year remission maintained by 6,272 mg (3,920 mg/m2) cumulative dose of cisplatin-based chemotherapy for recurrent epithelial ovarian cancerM S PiverEuropean Journal of Gynaecological Oncology|March 5, 2002
Estrogen receptor expression in an endometrial stromal sarcoma after tamoxifen therapyJ B Liao, J Y LinEuropean Journal of Gynaecological Oncology|March 5, 2002
Piver's radical hysterectomy (type III): Endo-Gia 30 stapler versus traditional forcipressure for resection of the cardinal ligamentP Scollo, G Scibilia, F Nocera, et al.European Journal of Gynaecological Oncology|March 5, 2002
Glutathione S-transferases P1-1 and A1-1 in ovarian cyst fluidsE A Boss, W H Peters, H M Roelofs, et al.European Journal of Gynaecological Oncology|March 5, 2002
The role of chemotherapy in malignant mixed mullerian tumors of the female genital tractE Topuz, Y Eralp, A Aydiner, et al.European Journal of Gynaecological Oncology|March 6, 2002
Correlation between atypical colposcopy findings and detection of human papillomavirus (HPV) infection of the uterine cervixM Perovic, M Berisavac, N Kuljic-Kapulica, et al.European Journal of Gynaecological Oncology|March 6, 2002
Strategies for the modification of risk factors in gynecological cancersJ L Benedet, L Cabero-RouraEuropean Journal of Gynaecological Oncology|March 6, 2002
Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot studyZ Holub, A Jabor, L KlimentEuropean Journal of Gynaecological Oncology|March 6, 2002
Unthreatened late pregnancy with a huge mucinous cyst adenoma of the left ovary: report of an unusual caseO Balat, I Kutlar, S Erkiliç, et al.European Journal of Gynaecological Oncology|March 7, 2002
Drug resistance in epithelial ovarian cancer: P-glycoprotein and glutation S-transferase. Can they play an important role in detecting response to platinum-based chemotherapy as a first-line therapyT Simşek, G Ozbilim, H Gülkesen, et al.Pageof 393